Article Information
History
- December 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ugur Sahin1,2,*,
- Alexander Muik1,
- Isabel Vogler1,
- Evelyna Derhovanessian1,
- Lena M. Kranz1,
- Mathias Vormehr1,
- Jasmin Quandt1,
- Nicole Bidmon1,
- Alexander Ulges1,
- Alina Baum5,
- Kristen Pascal5,
- Daniel Maurus1,
- Sebastian Brachtendorf1,
- Verena Lörks1,
- Julian Sikorski1,
- Peter Koch1,
- Rolf Hilker1,
- Dirk Becker1,
- Ann-Kathrin Eller1,
- Jan Grützner1,
- Manuel Tonigold1,
- Carsten Boesler1,
- Corinna Rosenbaum1,
- Ludwig Heesen1,
- Marie-Cristine Kühnle1,
- Asaf Poran3,
- Jesse Z. Dong3,
- Ulrich Luxemburger1,
- Alexandra Kemmer-Brück1,
- David Langer1,
- Martin Bexon8,
- Stefanie Bolte1,
- Tania Palanche1,
- Armin Schultz7,
- Sybille Baumann7,
- Azita J. Mahiny1,
- Gábor Boros1,
- Jonas Reinholz1,
- Gábor T. Szabó1,
- Katalin Karikó1,
- Pei-Yong Shi6,
- Camila Fontes-Garfias6,
- John L. Perez4,
- Mark Cutler4,
- David Cooper4,
- Christos A. Kyratsous5,
- Philip R. Dormitzer4,
- Kathrin U. Jansen4 and
- Özlem Türeci1
- 1BioNTech, An der Goldgrube 12, 55131 Mainz, Germany
- 2TRON gGmbH – Translational Oncology at the University Medical Center of the Johannes Gutenberg, University Freiligrathstraße 12, 55131 Mainz, Germany
- 3BioNTech US, 40 Erie Street, Suite 110, Cambridge, MA 02139, U.S.A.
- 4Pfizer, 401 N Middletown Rd., Pearl River, NY 10960, U.S.A.
- 5Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY 10591, U.S.A.
- 6University of Texas Medical Branch, Galveston, TX 77555, U.S.A.
- 7CRS Clinical Research Services Mannheim GmbH, Grenadierstrasse 1, 68167 Mannheim, Germany
- 8Bexon Clinical Consulting LLC, Upper Montclair, NJ 07043, U.S.A.
- ↵*Correspondence:
Ugur Sahin, BioNTech, An der Goldgrube 12, 55131 Mainz, Germany, Tel: +49 6131 9084 1801, Email: Ugur.Sahin{at}biontech.de